UK markets closed

Atossa Therapeutics, Inc. (ATOS)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.7800-0.0479 (-5.79%)
As of 02:49PM EST. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts0010
Avg. Estimate00-0.220
Low estimate00-0.220
High estimate00-0.220
Year ago EPS-0.04-0.04-0.18-0.22
Revenue estimateCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
No. of analysts1111
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history30/12/202130/03/202229/06/202229/09/2022
Est. EPS-0.04-0.05-0.06-0.06
Actual EPS-0.04-0.04-0.05-0.06
Difference00.010.010
Surprise %0.00%20.00%16.70%0.00%
EPS trendCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Current estimate00-0.220
7 days ago-0.06-0.06-0.22-0.22
30 days ago-0.06-0.06-0.22-0.22
60 days ago-0.06-0.06-0.22-0.22
90 days ago-0.06-0.06-0.2-0.22
EPS revisionsCurrent qtr. (Dec 2022)Next qtr. (Mar 2023)Current year (2022)Next year (2023)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesATOSIndustrySector(s)S&P 500
Current qtr.N/AN/AN/AN/A
Next qtr.N/AN/AN/AN/A
Current year-22.20%N/AN/AN/A
Next yearN/AN/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A